Long-term duloxetine treatment normalizes altered brain-derived neurotrophic factor expression in serotonin transporter knockout rats through the modulation of specific neurotrophin isoforms

Molecular Pharmacology

Volumn 77, Issue 5, 2010, Pages 846-853

  Calabrese, Francesca ^a   Molteni, Raffaella ^a   Cattaneo, Annamaria ^b,d   Macchi, Flavia ^a   Racagni, Giorgio ^a,b   Gennarelli, Massimo ^b,d   Ellenbroek, Bart A ^c   Riva, Marco A ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^c Evotec Technologies GmbH   (Germany)

^d UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DULOXETINE; ETHYLNITROSOUREA; SEROTONIN TRANSPORTER;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FRONTAL CORTEX; GENE EXPRESSION; GENOTYPE; HIPPOCAMPUS; LONG TERM CARE; MAJOR DEPRESSION; NERVE CELL PLASTICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SEROTONINERGIC SYSTEM; WESTERN BLOTTING;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; FRONTAL LOBE; GENE EXPRESSION REGULATION; HIPPOCAMPUS; NERVE GROWTH FACTORS; PREFRONTAL CORTEX; RATS; RATS, TRANSGENIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; THIOPHENES;

EID: 77951075407     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.109.063081     Document Type: Article

References (39)

1. Aid T, Kazantseva A, Piirsoo M, Palm K, and Timmusk T (2007) Mouse and rat BDNF gene structure and expression revisited. J Neurosci Res 85:525-535. (Pubitemid 46318317)
2. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J, Bukhman YV, Young TA, Charles V, and Palfreyman MG (2004) Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. J Neurosci 24:2667-2677. (Pubitemid 38380943)
3. An JJ, Gharami K, Liao GY, Woo NH, Lau AG, Vanevski F, Torre ER, Jones KR, Feng Y, Lu B, et al. (2008) Distinct role of long 3′ UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134:175-187.
4. Berton O and Nestler EJ (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat Rev Neurosci 7:137-151. (Pubitemid 43151600)
5. Calabrese F, Molteni R, Maj PF, Cattaneo A, Gennarelli M, Racagni G, and Riva MA (2007) Chronic duloxetine treatment induces specific changes in the expression of BDNF transcripts and in the subcellular localization of the neurotrophin protein. Neuropsychopharmacology 32:2351-2359. (Pubitemid 47587673)
6. Calabrese F, Molteni R, Racagni G, and Riva MA (2009) Neuronal plasticity: a link between stress and mood disorders. Psychoneuroendocrinology 34:S208-S216.
7. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301:386-389. (Pubitemid 36877077)
8. Castrén E, Võikar V, and Rantamäki T (2007) Role of neurotrophic factors in depression. Curr Opin Pharmacol 7:18-21.
9. Cattaneo A, Sesta A, Calabrese F, Nielsen G, Riva MA and Gennarelli M (2010) The expression of VGF is reduced in leukocytes of depressed patients and it is restored by effective antidepressant treatment. Neuropsychopharmacology doi:10.1038/npp.2010.11.
10. Chiaruttini C, Sonego M, Baj G, Simonato M, and Tongiorgi E (2008) BDNF mRNA splice variants display activity-dependent targeting to distinct hippocampal laminae. Mol Cell Neurosci 37:11-19. (Pubitemid 350299994)
11. Duman RS (2009) Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci 11:239-255.
12. Dwivedi Y, Rizavi HS, and Pandey GN (2006) Antidepressants reverse corticosterone-mediated decrease in brain-derived neurotrophic factor expression: differential regulation of specific exons by antidepressants and corticosterone. Neuroscience 139:1017-1029.
13. Fumagalli F, Bedogni F, Perez J, Racagni G, and Riva MA (2004) Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress. Eur J Neurosci 20:1348-1354. (Pubitemid 39233585)
14. Ghosh A, Carnahan J, and Greenberg ME (1994) Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263:1618-1623. (Pubitemid 24128367)
15. Groves JO (2007) Is it time to reassess the BDNF hypothesis of depression? Mol Psychiatry 12:1079-1088.
16. Holmes A, Lit Q, Murphy DL, Gold E, and Crawley JN (2003) Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2:365-380. (Pubitemid 37463201)
17. Homberg JR, Olivier JD, Smits BM, Mul JD, Mudde J, Verheul M, Nieuwenhuizen OF, Cools AR, Ronken E, Cremers T, et al. (2007) Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146:1662-1676. (Pubitemid 46783222)
18. Huezo-Diaz P, Uher R, Smith R, Rietschel M, Henigsberg N, Marusic A, Mors O, Maier W, Hauser J, Souery D, et al. (2009) Moderation of antidepressant response by the serotonin transporter gene. Br J Psychiatry 195:30-38.
19. Hunsberger JG, Newton SS, Bennett AH, Duman CH, Russell DS, Salton SR, and Duman RS (2007) Antidepressant actions of the exercise-regulated gene VGF. Nat Med 13:1476-1482.
20. Kalueff AV, Olivier JD, Nonkes LJ, and Homberg JR (2010) Conserved role for the serotonin transporter gene in rat and mouse neurobehavioral endophenotypes. Neurosci Biobehav Rev 34:373-386.
21. Kozisek ME, Middlemas D, and Bylund DB (2008) Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol Ther 117:30-51. (Pubitemid 350192670)
22. Lira A, Zhou M, Castanon N, Ansorge MS, Gordon JA, Francis JH, Bradley-Moore M, Lira J, Underwood MD, Arango V, et al. (2003) Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54:960-971. (Pubitemid 37415032)
23. Lucki I (1998) The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44:151-162.
24. Martinowich K, Manji H, and Lu B (2007) New insights into BDNF function in depression and anxiety. Nat Neurosci 10:1089-1093. (Pubitemid 47339961)
25. McClung CA and Nestler EJ (2008) Neuroplasticity mediated by altered gene expression. Neuropsychopharmacology 33:3-17.
26. Molteni R, Calabrese F, Cattaneo A, Mancini M, Gennarelli M, Racagni G, and Riva MA (2009) Acute stress responsiveness of the neurotrophin BDNF in the rat hippocampus is modulated by chronic treatment with the antidepressant duloxetine. Neuropsychopharmacology 34:1523-1532.
27. Molteni R, Cattaneo A, Calabrese F, Macchi F, Olivier JD, Racagni G, Ellenbroek BA, Gennarelli M, and Riva MA (2010) Reduced function of the serotonin transporter is associated with decreased expression of BDNF in rodents as well as in humans. Neurobiol Dis 37:747-755.
28. Molteni R, Fumagalli F, Magnaghi V, Roceri M, Gennarelli M, Racagni G, Melcangi RC, and Riva MA (2001) Modulation of fibroblast growth factor-2 by stress and corticosteroids: from developmental events to adult brain plasticity. Brain Res Brain Res Rev 37:249-258. (Pubitemid 34020735)
29. Olivier JD, Van Der Hart MG, Van Swelm RP, Dederen PJ, Homberg JR, Cremers T, Deen PM, Cuppen E, Cools AR, and Ellenbroek BA (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152:573-584.
30. Paxinos G and Watson C (1996). The Rat Brain in Stereotaxis Coordinates, Academic Press, New York.
31. Pittenger C and Duman RS (2008) Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 33:88-109.
32. Pittenger C, Sanacora G, and Krystal JH (2007) The NMDA receptor as a therapeutic target in major depressive disorder. CNS Neurol Disord Drug Targets 6:101-115. (Pubitemid 46681771)
33. Sen S, Duman R, and Sanacora G (2008) Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 64:527-532.
34. Smits BM, Mudde JB, van de Belt J, Verheul M, Olivier J, Homberg J, Guryev V, Cools AR, Ellenbroek BA, Plasterk RH, et al. (2006) Generation of gene knockouts and mutant models in the laboratory rat by ENU-driven target-selected mutagenesis. Pharmacogenet Genomics 16:159-169. (Pubitemid 43312578)
35. Thakker-Varia S, Krol JJ, Nettleton J, Bilimoria PM, Bangasser DA, Shors TJ, Black IB, and Alder J (2007) The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus. J Neurosci 27:12156-12167. (Pubitemid 350085466)
36. Timmusk T, Palm K, Metsis M, Reintam T, Paalme V, Saarma M, and Persson H (1993) Multiple promoters direct tissue-specific expression of the rat BDNF gene. Neuron 10:475-489. (Pubitemid 23111738)
37. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, and Nestler EJ (2006) Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 9:519-525.
38. Turner CA, Akil H, Watson SJ, and Evans SJ (2006) The fibroblast growth factor system and mood disorders. Biol Psychiatry 59:1128-1135. (Pubitemid 43912555)
39. Uher R and McGuffin P (2008) The moderation by the serotonin transporter gene of environmental adversity in the aetiology of mental illness: review and methodological analysis. Mol Psychiatry 13:131-146.